You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 9, September 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence and Brief Communications
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Oncology, Other
 •Surgical Oncology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ablative Therapy of Malignant Liver Neoplasm—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Thank you for your comments to our recently published article. The purpose of our study was to perform a systematic review of the current literature on RFA. We had strict criteria as to which studies could be included. We agree that there is evidence that combining hepatic blood flow interruption with RFA has been shown to reduce the rate of tumor recurrence and increase the size of the lesion that is able to be ablated, and the long-term result appears better than with radiofrequency alone. At the time of preparation of our review, there was no such study available that fit our inclusion criteria.

In terms of long-term survival for patients undergoing one of these procedures, there are few long-term data yet available. Many studies have quoted figures for 5-year survival, yet these are often actuarial. This applies to the study by Pacella et al,1 so we have . . . [Full Text of this Article]


AUTHOR INFORMATION
Guy J. Maddern, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Ablative Therapy of Malignant Liver Neoplasm
M. Badruddoja
Arch Surg. 2006;141(9):947.
EXTRACT | FULL TEXT  

Radiofrequency Ablation of Liver Tumors: A Systematic Review
Leanne M. Sutherland, John A. R. Williams, Robert T. A. Padbury, David C. Gotley, Bryant Stokes, and Guy J. Maddern
Arch Surg. 2006;141(2):181-190.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.